Cipla gets USFDA nod for hypertension, cardiac drug
Cipla said, Metoprolol succinate extended-release tablets are indicated for the treatment of hypertension, to lower blood pressure, Angina Pectoris (chest pain or discomfort due to coronary heart disease).
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Cardiology | Coronary Heart Disease | Heart | Heart Disease | Hypertension | Pain | Toprol